Company intelligence / Profile preview

Hemanext

Lexington, Massachusetts, United Stateshemanext.com ↗

Ownership: Private
Development stage: Commercial

Overview

Hemanext has developed the Hemanext ONE system, a novel device that processes and stores red blood cells under hypoxic conditions to reduce oxidative damage ("storage lesion"). The product has received CE Mark certification in Europe with initial commercial orders placed. In the US, it has FDA authorization for specific use cases. Clinical trials are ongoing to further evaluate efficacy and safety across multiple patient populations. Post-market studies have been completed for cancer and burn patients.

Therapeutic areas: Hematology
Modalities: Device (blood processing and storage system)Non-pharmacological therapy (transfusion support)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Hemanext ONE

Commercial

Indications: Thalassemia, Sickle cell disease, Myelodysplastic syndromes, Acute bleeding, Trauma, Surgery

Partnerships

Hemara Bio (exclusive distribution agreement for GCC region/UAE)Distributors in Nordics & Italy for European rollout

Beyond the preview

Go deeper on Hemanext.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemanext.

Explore the full profile